145 related articles for article (PubMed ID: 14668799)
1. Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation.
Watamoto K; Towatari M; Ozawa Y; Miyata Y; Okamoto M; Abe A; Naoe T; Saito H
Oncogene; 2003 Dec; 22(57):9176-84. PubMed ID: 14668799
[TBL] [Abstract][Full Text] [Related]
2. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.
Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T
Exp Cell Res; 1998 Nov; 245(1):186-94. PubMed ID: 9828115
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the transcriptional factor GATA-1 in regulation of expression of coproporphyrinogen oxidase in mouse erythroleukemia cells.
Tanabe A; Furukawa T; Ogawa Y; Yamamoto M; Hayashi N; Tokunaga R; Taketani S
Biochem Biophys Res Commun; 1997 Apr; 233(3):729-36. PubMed ID: 9168923
[TBL] [Abstract][Full Text] [Related]
4. Class II histone deacetylases: structure, function, and regulation.
Bertos NR; Wang AH; Yang XJ
Biochem Cell Biol; 2001; 79(3):243-52. PubMed ID: 11467738
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 3 associates with and represses the transcription factor GATA-2.
Ozawa Y; Towatari M; Tsuzuki S; Hayakawa F; Maeda T; Miyata Y; Tanimoto M; Saito H
Blood; 2001 Oct; 98(7):2116-23. PubMed ID: 11567998
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation.
Chang TJ; Scher BM; Waxman S; Scher W
Mol Endocrinol; 1993 Apr; 7(4):528-42. PubMed ID: 8502237
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
Grégoire S; Xiao L; Nie J; Zhang X; Xu M; Li J; Wong J; Seto E; Yang XJ
Mol Cell Biol; 2007 Feb; 27(4):1280-95. PubMed ID: 17158926
[TBL] [Abstract][Full Text] [Related]
8. Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1.
Choe KS; Radparvar F; Matushansky I; Rekhtman N; Han X; Skoultchi AI
Cancer Res; 2003 Oct; 63(19):6363-9. PubMed ID: 14559825
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
10. Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1.
Choi Y; Elagib KE; Delehanty LL; Goldfarb AN
Cancer Res; 2006 Mar; 66(6):2990-6. PubMed ID: 16540647
[TBL] [Abstract][Full Text] [Related]
11. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
Chen J; Kremer CS; Bender TP
Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
[TBL] [Abstract][Full Text] [Related]
12. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation.
Blobel GA; Nakajima T; Eckner R; Montminy M; Orkin SH
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2061-6. PubMed ID: 9482838
[TBL] [Abstract][Full Text] [Related]
13. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of erythropoiesis: an affair involving multiple partners.
Cantor AB; Orkin SH
Oncogene; 2002 May; 21(21):3368-76. PubMed ID: 12032775
[TBL] [Abstract][Full Text] [Related]
15. LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1.
Osada H; Grutz GG; Axelson H; Forster A; Rabbitts TH
Leukemia; 1997 Apr; 11 Suppl 3():307-12. PubMed ID: 9209374
[TBL] [Abstract][Full Text] [Related]
16. Purification of human recombinant GATA-1 from bacteria: implication for protein-protein interaction studies.
Doubeikovskaia Z; Aries A; Jeannesson P; Morle F; Doubeikovski A
Protein Expr Purif; 2001 Dec; 23(3):426-31. PubMed ID: 11722179
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of the binding of GATA factors to the regulatory elements of human beta-globin gene in hydroxyurea-induced and uninduced HEL cells].
Zhao H; Zhang SB; Jiang S; Qian RL
Shi Yan Sheng Wu Xue Bao; 1999 Sep; 32(3):243-9. PubMed ID: 12548806
[TBL] [Abstract][Full Text] [Related]
18. GATA-1: friends, brothers, and coworkers.
Morceau F; Schnekenburger M; Dicato M; Diederich M
Ann N Y Acad Sci; 2004 Dec; 1030():537-54. PubMed ID: 15659837
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta.
Maltepe E; Krampitz GW; Okazaki KM; Red-Horse K; Mak W; Simon MC; Fisher SJ
Development; 2005 Aug; 132(15):3393-403. PubMed ID: 15987772
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of hematopoietic transcription factor complexes by in vivo biotinylation tagging and mass spectrometry.
Grosveld F; Rodriguez P; Meier N; Krpic S; Pourfarzad F; Papadopoulos P; Kolodziej K; Patrinos GP; Hostert A; Strouboulis J
Ann N Y Acad Sci; 2005; 1054():55-67. PubMed ID: 16339652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
